Skip to main content
Clinical Trials/IRCT20231031059919N1
IRCT20231031059919N1
Recruiting
Phase 3

Investigating the effect of magnesium sulfate nebulization in children with cystic fibrosis

Mashhad University of Medical Sciences0 sites34 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
E84.0
Sponsor
Mashhad University of Medical Sciences
Enrollment
34
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Suffering from cystic fibrosis
  • Over 6 years old
  • Ability to perform spirometry
  • FEV1 above 60%

Exclusion Criteria

  • Nnon\-cooperation in the continuation of the intervention
  • Drug intolerance
  • Nebulizer intolerance
  • The patient's entry into the exacerbation phase
  • Inability to perform spirometry

Outcomes

Primary Outcomes

Not specified

Similar Trials